Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cell Origin Biotech (hangzhou) Co., Ltd.

Clinical trials sponsored by Cell Origin Biotech (hangzhou) Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Experimental immune cells take on tough tumors Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Experimental immune cells take on tough tumors

Disease control Recruiting now

This early trial tests a new treatment called SY001, which uses a patient's own immune cells (macrophages) engineered to attack cancer cells that have a protein called mesothelin. The study includes just 2 people with advanced ovarian or pancreatic cancer who have not responded t…

Sponsor: Cell Origin Biotech (Hangzhou) Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC